We are live on ! Find out more
BEAM icon

Beam Therapeutics
BEAM

221 hedge funds and large institutions have $1.94B invested in Beam Therapeutics in 2024 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 75 increasing their positions, 67 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more call options, than puts

Call options by funds: $12.1M | Put options by funds: $6.22M

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

42% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 19

12% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 67

6% more capital invested

Capital invested by funds: $1.82B → $1.94B (+$117M)

3% more funds holding

Funds holding: 214 → 221 (+7)

1.63% more ownership

Funds ownership: 94.28% → 95.9% (+1.6%)

Holders
221
Holders Change
+7
Holders Change %
+3.27%
% of All Funds
3.17%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
27
Increased
75
Reduced
67
Closed
19
Calls
$12.1M
Puts
$6.22M
Net Calls
+$5.84M
Net Calls Change
-$3.6M

Top Buyers

1
NAMA
Nikko Asset Management Americas
New York
+$34.3M
2
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
+$34.3M
3
KCM
Kynam Capital Management
New Jersey
+$33.6M
4
Citadel Advisors
Citadel Advisors
Florida
+$18.8M
5
LGM
Logos Global Management
California
+$12.9M

Top Sellers

1
First Trust Advisors
First Trust Advisors
Illinois
-$37.8M
2
AIM
ARK Investment Management
Florida
-$28.3M
3
Deutsche Bank
Deutsche Bank
Germany
-$21.1M
4
AVM
Arch Venture Management
Illinois
-$15.7M
5
Norges Bank
Norges Bank
Norway
-$10.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
FCM
1
Farallon Capital Management
California
$201M +$7.62M +295,000 +4%
Vanguard Group
2
Vanguard Group
Pennsylvania
$192M -$1.44M -55,773 -0.7%
BlackRock
3
BlackRock
New York
$190M +$2.94M +113,885 +1%
AIM
4
ARK Investment Management
Florida
$160M -$28.3M -1,095,040 -14%
AVM
5
Arch Venture Management
Illinois
$118M -$15.7M -608,386 -11%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$103M -$5.07M -196,178 -4%
State Street
7
State Street
Massachusetts
$96.3M +$11.3M +437,402 +13%
NAMA
8
Nikko Asset Management Americas
New York
$87M +$34.3M +1,328,414 +60%
Sumitomo Mitsui Trust Group
9
Sumitomo Mitsui Trust Group
Japan
$87M +$34.3M +1,328,414 +60%
MM
10
MWG Management
British Virgin Islands
$55.5M – – –
Temasek Holdings
11
Temasek Holdings
Singapore
$44.4M – – –
Geode Capital Management
12
Geode Capital Management
Massachusetts
$44.3M +$2.02M +78,102 +5%
RG
13
Redmile Group
California
$39.5M -$2.38M -92,048 -5%
BG
14
Bellevue Group
Switzerland
$37.2M +$2.58M +100,000 +7%
Citadel Advisors
15
Citadel Advisors
Florida
$36.7M +$18.8M +727,041 +95%
T. Rowe Price Associates
16
T. Rowe Price Associates
Maryland
$36.4M +$2.39M +92,635 +7%
KCM
17
Kynam Capital Management
New Jersey
$31.9M +$33.6M +1,302,085 New
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$30.4M +$4.93M +190,971 +18%
Morgan Stanley
19
Morgan Stanley
New York
$29.6M +$10.4M +403,928 +50%
CC
20
Casdin Capital
New York
$19M +$2.58M +100,000 +15%
YCM
21
Yiheng Capital Management
California
$18.7M -$2.11M -81,740 -10%
Northern Trust
22
Northern Trust
Illinois
$16.9M +$871K +33,709 +5%
Goldman Sachs
23
Goldman Sachs
New York
$16.7M -$2.68M -103,715 -13%
JP Morgan Chase
24
JP Morgan Chase
New York
$15.7M -$1.31M -50,827 -7%
Charles Schwab
25
Charles Schwab
California
$15.4M +$936K +36,226 +6%
1
2 3 4 5

BEAM Hedge Fund Activity: Q3 2024 in Review

221 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Beam Therapeutics (BEAM) for Q3 2024, worth a combined $1.94B — up 6.4% from $1.82B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new BEAM positions and 19 closed out — a net gain of 8 holders — while 75 added to existing stakes and 67 trimmed.

The largest buyer was Nikko Asset Management Americas, adding an estimated $34.3M. The largest seller was First Trust Advisors, cutting an estimated $37.8M.

  • 221 institutional investors held Beam Therapeutics (BEAM) as of Q3 2024, up from 214 in Q2 2024.
  • Funds reported $1.94B of Beam Therapeutics stock for Q3 2024, up 6.4% quarter-over-quarter.
  • 27 funds opened new Beam Therapeutics positions in Q3 2024 and 19 closed out, a net change of +8 holders.
  • The largest Beam Therapeutics buyer in Q3 2024 was Nikko Asset Management Americas, an estimated $34.3M added.
  • The largest Beam Therapeutics seller in Q3 2024 was First Trust Advisors, an estimated $37.8M sold.

Based on aggregated 13F filings for Q3 2024.